Skin of Color
Joel Schlessinger, MD
Neal Bhatia, MD, FAAD
Tips for developing a comprehensive action plan with realistic short- and long-term goals and objectives to improve your practice.
EHRs, e-prescribing, and other digital technologies are becoming increasingly indifferent to government incentives.
Mark Kaufmann, MD
A decision algorithm for pigmented skin lesions.
Cliff Rosendahl, MBBS, PhD
For patients at high-risk for NMSC, chemoprevention can be a relatively safe and effective treatment approach.
Neal Bhatia, MD
Several factors including age, location, and risk of recurrence play an important role in the diagnosis and treatment selection of BCCs.
David A. Rodriguez, MD
Physicians' clinical decision-making and abilities to convey information to patients play a critical role in the utility of evolving melanoma detection devices.
Gary Goldenberg, MD
There are opportunities for ongoing dermatology therapy development.
William Ju MD, John Doux MD, and Frederick Beddingfield MD, PhD
Patients with nail dystrophy may be more concerned with the appearance of their nails than an underlying etiology.
A Q&A with Risha Bellomo, PA-C
Will your practice be prepared when CMS posts Sunshine disclosures later this year?
Steven J. Cagnetta, Esq, and Steven K. Ladd
Offer direct strategies for managing itch—from the inside and out.
Jeannette Graf, MD
Important questions to ask to find out what your advisor is doing for you.
David B. Mandell, JD, MBA and Andrew Taylor, CFP
Microneedle resurfacing has quickly become one of the most in-demand aesthetic procedures, likely due to its strong results, quick healing times, and cost-effectiveness.
Nancy J. Samolitis, MD
Stay up to date on all things Dermatology by signing up to recieve our print publication or subscribe to our email alerts.
July 2014 Insert